×
About 109,300 results

ALLMedicine™ Hepatitis Center

Research & Reviews  37,550 results

Psychosocial Barriers and Their Impact on Hepatocellular Carcinoma Care in US Veterans: Tumor Board Model of Care
https://www.mdedge.com/fedprac/article/254637/hepatocellular-carcinoma/psychosocial-barriers-and-their-impact
Parul D. Agarwal, MD, Beth A. Haftoglou, RN et. al.

May 16th, 2022 - Hepatocellular carcinoma (HCC) remains a major global health problem and is the third leading cause of cancer-related mortality worldwide. 1 Management of HCC is complex; as it largely occurs in the background of chronic liver disease, its manageme.

Review article: current and emerging therapies for acute alcohol-associated hepatitis.
https://doi.org/10.1111/apt.16969
Alimentary Pharmacology & Therapeutics; Rattan P, Shah VH

May 15th, 2022 - Alcohol-associated hepatitis is an acute manifestation of alcohol-associated liver disease (ALD) and is associated with 30%-40% mortality at 28 days. Abstinence and corticosteroids are the mainstays of treatment, but the latter only improves short...

STAT3 cooperates with AR/CCRK signaling pathway in the progression of HBV infection and...
https://doi.org/10.1111/jvh.13699
Journal of Viral Hepatitis; Xu Y, Qi W et. al.

May 15th, 2022 - The study aimed to investigate the role of AR/CCRK signaling pathway in chronic hepatitis B virus (HBV) infection and gender differences, and the contribution of AR regulatory factor STAT3 in it. AR, CCRK, and phosphorylated STAT3 expressions in l...

Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role ...
https://doi.org/10.1002/hep.32572
Hepatology (Baltimore, Md.); Efe C, Kulkarni AV et. al.

May 15th, 2022 - A few case reports of autoimmune hepatitis like liver injury have been reported after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. We evaluated clinical features, treatment response and outcomes of liver injury followi...

see more →

Guidelines  105 results

KASL clinical practice guidelines for management of chronic hepatitis B.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013624
Clinical and Molecular Hepatology;

Apr 18th, 2022 - KASL clinical practice guidelines for management of chronic hepatitis B.|2022| ,|therapeutic use,genetics,drug therapy,

Universal Hepatitis B Vaccination in Adults Aged 19-59 Years: Updated Recommendations o...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979596
MMWR. Morbidity and Mortality Weekly Report; Weng MK, Doshani M et. al.

Apr 1st, 2022 - Hepatitis B (HepB) vaccines have demonstrated safety, immunogenicity, and efficacy during the past 4 decades (1,2). However, vaccination coverage among adults has been suboptimal, limiting further reduction in hepatitis B virus (HBV) infections in...

Best practice guidelines for France regarding the diagnosis and management of autoimmun...
https://doi.org/10.1016/j.clinre.2022.101871
Clinics and Research in Hepatology and Gastroenterology; Duclos-Vallée JC, Debray D et. al.

Feb 3rd, 2022 - Best practice guidelines for France regarding the diagnosis and management of autoimmune hepatitis.|2022|Duclos-Vallée JC,Debray D,De Martin E,Beux EL,Louvet A,|

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP OF CHRONIC INFECTION WITH HEPATITIS B VIRUS.
https://doi.org/10.1016/j.clinre.2021.101773
Clinics and Research in Hepatology and Gastroenterology; Leroy V, Chevaliez S et. al.

Aug 1st, 2021 - Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the...

Non-invasive diagnosis and follow-up of autoimmune hepatitis.
https://doi.org/10.1016/j.clinre.2021.101772
Clinics and Research in Hepatology and Gastroenterology; Lemoinne S, Heurgue A et. al.

Aug 1st, 2021 - Autoimmune hepatitis (AIH) is a liver disease characterised by necrotico-inflammatory lesions of hepatocytes, the presence of specific autoantibodies and response to corticosteroid treatment. AIH must be considered in any patient with acute or chr...

see more →

Drugs  427 results see all →

Clinicaltrials.gov  1,541 results

Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia
https://clinicaltrials.gov/ct2/show/NCT04926285

May 13th, 2022 - This is a Phase Ib study of VEN and OM, the investigator will conduct a Bayesian Optimal Interval-designed trial following the approach of Yuan et al 40 to find the MTD with a target DLT rate of 2%, 4 pre-specified doses, and between 24 and up to ...

Evaluation of Patients With Liver Disease
https://clinicaltrials.gov/ct2/show/NCT00001971

May 13th, 2022 - This is a general clinical research protocol to allow for evaluation, investigation and long-term follow up of patients who have an acute or chronic liver disease. The protocol is designed to study the natural history and pathogenesis of various l...

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
https://clinicaltrials.gov/ct2/show/NCT03520660

May 13th, 2022 - We intend to enroll up to 350 subjects with chronic hepatitis C virus (HCV) infection. Subjects will be recruited from two sources: Phase I: treatment naive or experienced who have failed a prior treatment (including DAA-experienced) who are willi...

Treatment of Hepatitis c by Using Direct-acting Antiviral
https://clinicaltrials.gov/ct2/show/NCT05372874

May 13th, 2022 - Patients with hepatitis c showed increased level of oxidative stress. Increased level of serum lipid peroxidation leads to the production of toxic mediators as malondialdehyde (MDA) which lead to disease progression. Chronic stress shunt tryptopha...

The Study on Clinical Outcome and Treatment Optimization of Chronic Hepatitis B Patients With Hypoviremia
https://clinicaltrials.gov/ct2/show/NCT05357183

May 12th, 2022 - Chronic hepatitis B seriously endangers the health of our people, especially the occurrence of liver cancer, which brings huge economic burden and life threat to our people. 84% - 92% of hepatocellular carcinoma (HCC) in China is related to chroni...

see more →

News  4,019 results

Psychosocial Barriers and Their Impact on Hepatocellular Carcinoma Care in US Veterans: Tumor Board Model of Care
https://www.mdedge.com/fedprac/article/254637/hepatocellular-carcinoma/psychosocial-barriers-and-their-impact
Parul D. Agarwal, MD, Beth A. Haftoglou, RN et. al.

May 16th, 2022 - Hepatocellular carcinoma (HCC) remains a major global health problem and is the third leading cause of cancer-related mortality worldwide. 1 Management of HCC is complex; as it largely occurs in the background of chronic liver disease, its manageme.

Smooth plaque on ankle
https://www.mdedge.com/familymedicine/article/254556/dermatology/smooth-plaque-ankle
MDedge Family Medicine;

May 12th, 2022 - A 4-mm punch biopsy of the annular border confirmed a diagnosis of localized granuloma annulare (GA). There is a long list of differential diagnoses for annular patches and plaques; it includes tinea corporis and important systemic diseases such a.

CDC Updates Guidelines for Hepatitis Outbreak Among Children
https://www.medscape.com/viewarticle/973893

May 12th, 2022 - The CDC updated its recommendations for doctors and public health officials regarding the unusual outbreak of acute hepatitis among children. As of May 5, the CDC and state health departments are investigating 109 children with hepatitis of unknow...

DOJ Complaint Flags HCV Drug Denials for People With Addiction
https://www.medscape.com/viewarticle/973791

May 11th, 2022 - A complaint filed with the US Department of Justice (DOJ) alleges that Alabama's Medicaid program is illegally denying curative drug treatment for hepatitis C virus (HCV) infection to people with substance use disorder. The complaint was filed May...

FDA Lifts Partial Clinical Hold Placed on Studies Evaluating Magrolimab in MDS and AML
https://www.onclive.com/view/fda-lifts-partial-clinical-hold-placed-on-studies-evaluating-magrolimab-in-mds-and-aml

May 7th, 2022 - The FDA has lifted a partial clinical hold that had been placed on studies examining magrolimab in combination with azacitidine following a review of comprehensive safety data collected from each trial, according to an announcement from Gilead Sci...

see more →

Patient Education  78 results see all →